Skip navigation

Enrich Scientific Exchange Through Innovative Digital Strategies and Global Collaboration

December 13-14, 2017
  • Philadelphia, PA

Scientific publications are the foundation on which a drug’s identity is created, playing a crucial part in all marketing and communications efforts behind the brand. As the life sciences industry’s leading event, CBI’s Publication Planning 2017 will provide in-depth content on and analysis of current practices and emerging regulations and technologies. CBI’s content is tailored to provide critical insights for life sciences companies, both large and small. Key topics addressed will include the new ICMJE data sharing requirements, adapting publications for global release, and the integration of new types of data, including HEOR, into publications.

The program will also cover the role of digital platforms for publication planning, as well as new opportunities to develop metrics to measure the efficacy of publications. Opportunities to improve collaboration, communication and streamlined workflows will also be examined.

In-Depth Programming and
Compelling Discussions On:

  • Understand the benefits of leveraging digital platforms for
    publications and examine strategies for building an
    effective digital strategy
  • Analyze challenges and opportunities with incorporating
    new types of information, including HEOR, into publications
  • Examine lay summaries, review articles, KOL pieces and their
    roles in targeting specific audiences for impactful engagement
  • Learn about tactics to execute an effective and coordinated
    global publication plan
  • Hear about developments in data sharing, data transparency
    and disclosures

Previous Attendee Acclaim:

As a first time attendee, I was able to hear from veteran publication leads and gained valuable learnings to implement immediately into my pub planning efforts.

Anonymous

The conference topics were all timely. The sessions were
a nice mix of presentations and discussion. Ample
networking opportunities were a plus, too.

Publications Manager, GSK

A friendly, open exchange of ideas and working
procedures for publication professionals.

Vice President, BelMed

I greatly enjoyed the panel discussion on the Sunshine Act.
It has provided very important information that I will
use in updating our publication policy.

Director, Medical Communications, BioMarin Pharmaceutical Inc.

Practical, relevant, interactive.

Executive Vice President, MedErgy HealthGroup

Knowledgeable speakers and interactive discussions, combined with a strong agenda, make this a
very worthwhile conference to attend.

Director, Scientific & Medical Publications, Janssen Research & Development

Publication Planning 2017

Enrich Scientific Exchange Through Innovative Digital Strategies and Global Collaboration

Scientific publications are the foundation on which a drug’s identity is created, playing a crucial part in all marketing and communications efforts behind the brand. As the life sciences industry’s leading event, CBI’s Publication Planning 2017 will provide in-depth content on and analysis of current practices and emerging regulations and technologies. CBI’s content is tailored to provide critical insights for life sciences companies, both large and small. Key topics addressed will include the new ICMJE data sharing requirements, adapting publications for global release, and the integration of new types of data, including HEOR, into publications.

The program will also cover the role of digital platforms for publication planning, as well as new opportunities to develop metrics to measure the efficacy of publications. Opportunities to improve collaboration, communication and streamlined workflows will also be examined.

In-Depth Programming and
Compelling Discussions On:

  • Understand the benefits of leveraging digital platforms for
    publications and examine strategies for building an
    effective digital strategy
  • Analyze challenges and opportunities with incorporating
    new types of information, including HEOR, into publications
  • Examine lay summaries, review articles, KOL pieces and their
    roles in targeting specific audiences for impactful engagement
  • Learn about tactics to execute an effective and coordinated
    global publication plan
  • Hear about developments in data sharing, data transparency
    and disclosures

Previous Attendee Acclaim:

As a first time attendee, I was able to hear from veteran publication leads and gained valuable learnings to implement immediately into my pub planning efforts.

Anonymous

The conference topics were all timely. The sessions were
a nice mix of presentations and discussion. Ample
networking opportunities were a plus, too.

Publications Manager, GSK

A friendly, open exchange of ideas and working
procedures for publication professionals.

Vice President, BelMed

I greatly enjoyed the panel discussion on the Sunshine Act.
It has provided very important information that I will
use in updating our publication policy.

Director, Medical Communications, BioMarin Pharmaceutical Inc.

Practical, relevant, interactive.

Executive Vice President, MedErgy HealthGroup

Knowledgeable speakers and interactive discussions, combined with a strong agenda, make this a
very worthwhile conference to attend.

Director, Scientific & Medical Publications, Janssen Research & Development